StableBody Technologies, LLC
SBT is uniquely positioned to bring a new dimension to cancer detection and treatment with renewed hope for cancer patients.
SBT uses proprietary bioinformatics and production methodologies to design, optimize, and produce highly functional protein reagents. SBT’s optimized reagents carry the designation CCFr, cold chain free reagent, and do not require refrigeration. Clinical reagents developed with SBT technology have considerable advantages for cancer diagnostics in sensitivity and cost, as well as innovative cancer treatments for the bio-pharmaceutical marketplace.